Cellebrite Sets Annual Shareholder Meeting for Sept 19
Ticker: CLBT · Form: 6-K · Filed: Aug 15, 2025 · CIK: 1854587
| Field | Detail |
|---|---|
| Company | Cellebrite Di Ltd. (CLBT) |
| Form Type | 6-K |
| Filed Date | Aug 15, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Cellebrite's AGM is Sept 19th in Petah Tikva. Mark your calendars.
AI Summary
Cellebrite DI Ltd. announced on August 15, 2025, that its Annual General Meeting of Shareholders will take place on September 19, 2025, at 4:00 p.m. Israel time. The meeting will be held at the company's offices located at 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel.
Why It Matters
This filing informs shareholders about the upcoming annual meeting where key corporate decisions and elections are typically made, impacting governance and future strategy.
Risk Assessment
Risk Level: low — This is a routine corporate announcement regarding an annual general meeting, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Cellebrite DI Ltd. (company) — Registrant
- September 19, 2025 (date) — Annual General Meeting date
- 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel (location) — Company's offices
FAQ
When is Cellebrite DI Ltd.'s Annual General Meeting of Shareholders scheduled?
The Annual General Meeting is scheduled for Friday, September 19, 2025.
What time will the Annual General Meeting be held?
The meeting will commence at 4:00 p.m. Israel time.
Where will the Annual General Meeting take place?
The meeting will be held at Cellebrite DI Ltd.'s offices at 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel.
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer announcing the date and location of the company's Annual General Meeting of Shareholders.
Does Cellebrite DI Ltd. file annual reports under Form 20-F or 40-F?
The filing indicates that Cellebrite DI Ltd. files annual reports under Form 20-F.
Filing Stats: 387 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2025-08-15 09:01:58
Filing Documents
- ea0253264-6k_cellebrite.htm (6-K) — 13KB
- ea025326401ex99-1_cellebrite.htm (EX-99.1) — 308KB
- ea025326401ex99-2_cellebrite.htm (EX-99.2) — 2KB
- ex99-1_001.jpg (GRAPHIC) — 11KB
- ex99-1_002.jpg (GRAPHIC) — 3KB
- ex99-1_003.jpg (GRAPHIC) — 2KB
- ex99-1_004.jpg (GRAPHIC) — 3KB
- ex99-1_005.jpg (GRAPHIC) — 3KB
- ex99-1_006.jpg (GRAPHIC) — 3KB
- ex99-1_007.jpg (GRAPHIC) — 3KB
- ex99-1_008.jpg (GRAPHIC) — 3KB
- ex99-2_001.jpg (GRAPHIC) — 520KB
- ex99-2_002.jpg (GRAPHIC) — 585KB
- 0001213900-25-077084.txt ( ) — 1890KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellebrite DI Ltd. August 15, 2025 By: /s/ Ayala Berler Shapira Ayala Berler Shapira, Adv. General Counsel 3